Dr. Bostick is a Principal at Orchard Capital, a Los-Angeles based family office and General Partner at OCV where he leads the healthcare vertical. He’s led investments that collectively have raised over $1B, including Rad AI, Praxis Precision Medicines, and TORL Biotherapeutics. He was selected to the Milken Institute Young Leaders Circle in 2024 and was recognized by Biocom in 2021 as one of ten life science trailblazers under 40. Prior to investing, he conducted research receiving 500+ citations in peer-reviewed journals across Computational Biology, Pharmacology, Physics, and Neuroscience. 

He completed postdoctoral work at Columbia University, a Ph.D. in Pharmacology at West Virginia University, and a B.S. in Biology at Cornell University.